Medico Intercontinental Ltd Share Price & Stock Analysis

Medico Intercontinental Ltd (BSE: 539938) is a Ahmedabad, Gujarat-based company in the Health Care Distributors industry. With a market capitalisation of ₹23 Cr, it ranks #4,526 by market cap among the 6,189 Indian listed companies on FinBizNet, and #6 of 11 in Health Care Distributors. At ₹22.60 (as of 26 Oct 2026), the share price is 47.4% below its 52-week high of ₹43.00 and 9.7% above its 52-week low of ₹20.61. The share price is down 34.9% over one year and down 13.2% over three months.

Key Metrics

Current Price₹22.60
Market Cap₹23 Cr
BSE Code539938
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Distributors
P/E Ratio-7.1
Return on Equity-27.14%
Return on Assets-1.03%
52-Week Range₹20.61 – ₹43.00
1-Year Price Change-34.9%
3-Month Price Change-13.2%
Beta (1Y)0.37
Dividend Yield0.00%
HeadquartersAhmedabad, Gujarat
Websitewww.medicointercontinental.com

Latest Quarterly Results — Q1 FY27

Revenue₹14 Cr
Net Profit₹1 Cr
Net Margin4.3%
EPS (Basic)₹0.61
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

About Medico Intercontinental Ltd

Medico Intercontinental Limited engages in the trading of pharmaceutical products. It offers products in the gastro, uro, nutrition, cosmetology, and other areas, as well as provides health devices and hospital related products. The company also provides general and derma range products in various forms, such as tablets, soft gelatine, capsules, dental, ointments, powders and sprays, liquids, ayurvedics, injectables, dry syrup, suspension, drops, infusion, soap, and nutritional; and medical FTF products, including antiseptic liquid, multipurpose cleaner, hand wash, immunity booster, and N95 face mask products, liquid, gel, and spray hand sanitizer, as well as eye drops. The company was formerly known as Intercontinental Leasing & Finance Company Limited and changed its name to Medico Intercontinental Limited in December 2018. Medico Intercontinental Limited was incorporated in 1984 and is based in Ahmedabad, India.

Products and Services

1. Trading-This segment engages in the trading of pharmaceutical products. 2. Finance-This segment financing services. 3. Unallocated Provision for Taxes / Deferred Tax-0 4. Other Non-Allocable Income-0

Business Segments

1. Trading-100%

Medico Intercontinental Ltd vs Peers — Health Care Distributors

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Trimurthi Ltd₹170 Cr49.17.99%—+48.6%
Achyut Healthcare Ltd₹168 Cr535.40.95%—+15.0%
Vaidya Sane Ayurved Laboratories₹154 Cr—11.99%—-43.5%
Balaxi Pharmaceuticals Ltd₹115 Cr81.40.59%₹81 Cr-50.2%
Chanfta Bhagat Pharma Ltd₹29 Cr9.72.91%—-5.1%
Medico Intercontinental Ltd₹23 Cr-7.1-27.14%₹14 Cr-34.9%
Rubra Medicaments Ltd.₹20 Cr13.412.67%—-37.7%
Zenlabs Ethica Ltd₹18 Cr-9.1-20.44%—-12.8%
Nexus Surgical & Medicare Ltd₹14 Cr18.651.41%—+76.5%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Medico Intercontinental Ltd?

Medico Intercontinental Ltd is trading at ₹22.60, with a market capitalisation of ₹23 Cr.

Which sector does Medico Intercontinental Ltd belong to?

Medico Intercontinental Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).

What are the key financial ratios of Medico Intercontinental Ltd?

Medico Intercontinental Ltd has a P/E of -7.1 and a return on equity of -27.14%.

What is the stock symbol of Medico Intercontinental Ltd?

Medico Intercontinental Ltd is listed on the BSE under the scrip code 539938.

How has Medico Intercontinental Ltd's share price moved over the past year?

Medico Intercontinental Ltd's share price is down 34.9% over one year and down 13.2% over three months. Its 52-week range is ₹20.61 to ₹43.00.

What were Medico Intercontinental Ltd's latest quarterly results?

In Q1 FY27, Medico Intercontinental Ltd reported revenue of ₹14 Cr and net profit of ₹1 Cr, with basic EPS of ₹0.61 (standalone, parsed from the company's exchange filing).

More on FinBizNet

Data as of 26 Oct 2026. Descriptive market data only — not investment advice.